Catching The NBFC Wave
Just why NBFC is the latest holy grail in financial services.
adar poonawalla
December 2023
January 2023
December 2022
September 2022
April 2022
January 2022
December 2021
July 2021
Adar Poonawalla-backed Poonawalla Fincorp jump 6% on strong Q3
The NBFC stock has grown three-fold in the last two years, from ₹98 on February 12, 2021, to ₹307 in intraday today, after Adar Poonawalla acquired the company.
Poonawalla Fincorp to sell its housing subsidiary to TPG for ₹3,900 crore
The deal is expected to optimise resource allocation as Poonawalla Fincorp focuses on consumer and MSME financing.
Poonawalla, The Mass Saviour
The owner of world's biggest vaccine maker is also known for his interest in social causes.
Serum to launch India's first indigenous cervical cancer vaccine
While the initial rollout will be for supplies to the government vaccination programme, commercial open sales may begin early 2023, says Adar Poonawalla.
Serum not making fresh vaccines amid surplus stock: Poonawalla
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
Serum's Poonawalla pitches for global pandemic treaty for free flow of vaccines
India has learned a lot and is in a stronger and better position to face any future wave or future pandemics, says Adar Poonawalla.
This Adar Poonawalla-backed stock rallied 500% in one year; do you own it?
This multibagger stock has risen from ₹47 per share on February 1, 2021, to ₹283 level currently, after Adar Poonawalla-led Rising Sun Holdings acquired a 60% stake in the company.
Common global rules must for new Covid drug trials: Adar Poonawalla
Poonawalla says the biggest learning from the pandemic has been the realisation that one should not make forward looking predictions, as things have been changing fast with Covid-19
Mix and match vaccines, says Kiran Mazumdar-Shaw
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
